Table 3 Summary of reduction in mobile outreach visits if an administration of risperidone long-acting injection was not required (over a two-week period)
Average Resource use | ASGC region: Major Cities | ASGC region: Inner Regional | ASGC region: Outer Regional | ASGC region: Remote & Very Remote | ||||
|---|---|---|---|---|---|---|---|---|
Mobile Outreach Visits by CMHC staff | 1 Staff Visits | ≥ 2 Staff Visits | 1 Staff Visits | ≥ 2 Staff Visits | 1 Staff Visits | ≥ 2 Staff Visits | 1 Staff Visits | ≥ 2 Staff Visits |
Mobile outreach visits (no.) | 9.3 | 4.6 | 6.6 | 2.7 | 3.2 | 1.2 | 4.0 | 2.14 |
Mobile outreach visits still required if a risperidone LAI administration was not required (no.) | 7.6 | 3.7 | 5.2 | 2.1 | 1.9 | 0.7 | 3.1 | 1.86 |
Reduction in outreach visits (%) | 18.0% | 19.6% | 21.2% | 22.5% | 41.7% | 38.9% | 21.4% | 13.3% |
National average reduction in mobile outreach visits if a risperidone LAI administration was not required | Â | Â | Â | Â | 20% | Â | Â | Â |